Evaluation of the 10% rescreen of negative gynecologic smears as a quality assurance measure.
about
Cervical premalignant lesions and their management.Analysis of telomerase as a diagnostic biomarker of cervical dysplasia and carcinoma.Use of a laboratory information system driven tool for pre-signout quality assurance of random cytopathology reports.Economic evaluation of DNA ploidy analysis vs liquid-based cytology for cervical screening.Evaluation of 100% rapid rescreening of negative cervical smears as a quality assurance measure.Comparison of the performance of rapid prescreening, 10% random review, and clinical risk criteria as methods of internal quality control in cervical cytopathology.
P2860
Evaluation of the 10% rescreen of negative gynecologic smears as a quality assurance measure.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Evaluation of the 10% rescreen ...... s a quality assurance measure.
@en
type
label
Evaluation of the 10% rescreen ...... s a quality assurance measure.
@en
prefLabel
Evaluation of the 10% rescreen ...... s a quality assurance measure.
@en
P2860
P1476
Evaluation of the 10% rescreen ...... s a quality assurance measure.
@en
P2093
P2860
P356
10.1002/(SICI)1097-0339(199602)14:1<84::AID-DC17>3.0.CO;2-9
P577
1996-02-01T00:00:00Z